An overview of the myocardial regeneration potential of cardiac c-Kit⁺ progenitor cells via PI3K and MAPK signaling pathways

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Wen Z, Mai Z, Zhang H et al. Local activation of cardiac stem cells for post-myocardial infarction cardiac repair. J. Cell. Mol. Med. 16(11), 2549–2563 (2012). •• Provides potential kinds of stem/progenitor cells for heart cell therapy.
  Medline CASGoogle Scholar
• 2. Li C, Matsushita S, Li Z et al. c-kit positive cardiac outgrowth cells demonstrate better ability for cardiac recovery against ischemic myopathy. J. Stem. Cell. Res. Ther. 7(10), 1–17 (2017).
  Google Scholar
• 3. Le T, Chong J. Cardiac progenitor cells for heart repair. Cell. Death Discov. 2 16052 (2016).
  MedlineGoogle Scholar
• 4. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clinic. Investig. 103(5), 697–705 (199).
  Google Scholar
• 5. Khan AR, Farid TA, Pathan A et al. Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis. Circ. Res. 118(6), 984–993 (2016).
  Medline CASGoogle Scholar
• 6. Nikravesh MR, Jalali M, Ghafaripoor HA et al. Therapeutic potential of umbilical cord blood stem cells on brain damage of a model of stroke. J. Cardiovasc. Thorac. Res. 3(4), 117–122 (2011).
  MedlineGoogle Scholar
• 7. Ahmed RP, Ashraf M, Buccini S et al. Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen. Med. 6(2), 171–178 (2011).
  CASGoogle Scholar
• 8. Zhang Y, Wang D, Chen M et al. Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS ONE 6(4), e19012 (2011).
  Medline CASGoogle Scholar
• 9. Bergmann O, Bhardwaj RD, Bernard S et al. Evidence for cardiomyocyte renewal in humans. Science 324(5923), 98–102 (2009).
  Medline CASGoogle Scholar
• 10. Bu L, Jiang X, Martin-Puig S et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460(7251), 113–117 (2009).
  Medline CASGoogle Scholar
• 11. Amini H, Rezaie J, Vosoughi A et al. Cardiac progenitor cells application in cardiovascular disease. J. Cardiovasc. Thorac. Res. 9(3), 127–132 (2017).
  MedlineGoogle Scholar
• 12. Hassanpour M, Cheraghi O, Siavashi V et al. A reversal of age-dependent proliferative capacity of endothelial progenitor cells from different species origin in in vitro condition. J. Cardiovasc. Thorac. Res. 8(3), 102–106 (2016).
  MedlineGoogle Scholar
• 13. Le T, Chong J. Cardiac progenitor cells for heart repair. Cell. Death Discov. 2(16052), 1–4 (2016).
  Google Scholar
• 14. Mozaffarian D, Benjamin EJ, Go AS et al. Heart disease and stroke statistics – 2016 update a report from the American Heart Association. Circulation 133(4), e38–e48 (2016). •• Provides considerable clinical trials and in vivo studies for heart regeneration.
  MedlineGoogle Scholar
• 15. Fernández-Avilés F, Sanz-Ruiz R, Climent A et al. TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee. Transl. Res. 2532–2546 (2017).
  Google Scholar
• 16. Fernández-Avilés F, Sanz-Ruiz R, Climent AM et al. Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) recommendations: a comprehensive series of challenges and priorities of cardiovascular regenerative medicine. Circ. Res. 122, 199–201 (2018).
  Medline CASGoogle Scholar
• 17. Povsic TJ, O'Connor CM, Henry T et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. J. Am. Heart Assoc. 162(4), 654–662. e651 (2011).
  Google Scholar
• 18. Gepstein L, Ding C, Rehemedula D et al. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 28(12), 2151–2161 (2010).
  MedlineGoogle Scholar
• 19. Martin-Rendon E, Brunskill SJ, Hyde CJ et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur. Heart J. 29(15), 1807–1818 (2008).
  Medline CASGoogle Scholar
• 20. Schächinger V, Erbs S, Elsässer A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J. 27(23), 2775–2783 (2006).
  MedlineGoogle Scholar
• 21. Stamm C, Kleine H-D, Choi Y-H et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 133(3), 717–725. e715 (2007).
  MedlineGoogle Scholar
• 22. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100(Suppl. 2), II-247–II-256 (1999).
  CASGoogle Scholar
• 23. Liu Y, Li Z, Liu T et al. Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarction. Cardiovasc. Diabetol. 12(1), 40–50 (2013).
  Medline CASGoogle Scholar
• 24. Lin X, Peng P, Cheng L et al. A natural compound induced cardiogenic differentiation of endogenous MSCs for repair of infarcted heart. Differentiation 83(1), 1–9 (2012).
  MedlineGoogle Scholar
• 25. Kocher A, Schuster M, Szabolcs M et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7(4), 430–436 (2001).
  Medline CASGoogle Scholar
• 26. Senyo SE, Steinhauser ML, Pizzimenti CL et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493(7432), 433–436 (2013). • Provides multipotency and pluripotency features of stem cells for myocardial regeneration.
  Medline CASGoogle Scholar
• 27. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6), 763–776 (2003).
  Medline CASGoogle Scholar
• 28. Chong JJ, Forte E, Harvey RP. Developmental origins and lineage descendants of endogenous adult cardiac progenitor cells. Stem. Cell. Res. 13(3 Pt B), 592–614 (2014).
  Medline CASGoogle Scholar
• 29. Anversa P. Myocyte death and growth in the failing heart. Lab. Invest. 78, 767–786 (1998).
  Medline CASGoogle Scholar
• 30. Laugwitz K-L, Moretti A, Lam J et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026), 647–653 (2005).
  Medline CASGoogle Scholar
• 31. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA. 100(21), 12313–12318 (2003).
  Medline CASGoogle Scholar
• 32. Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95(9), 911–921 (2004).
  Medline CASGoogle Scholar
• 33. Madigan M, Atoui R. Therapeutic use of stem cells for myocardial infarction. Bioengineering 5(2), 28–46 (2018).
  Google Scholar
• 34. Makkar RR, Smith RR, Cheng K et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised Phase I trial. Lancet 379(9819), 895–904 (2012).
  MedlineGoogle Scholar
• 35. Zhou B, Wu SM. Reassessment of c-Kit in cardiac cells: a complex interplay between expression, fate, and function. Circ. Res. 123(1), 9–11 (2018).
  Medline CASGoogle Scholar
• 36. Fransioli J, Bailey B, Gude NA et al. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 26(5), 1315–1324 (2008).
  Medline CASGoogle Scholar
• 37. Di Siena S, Gimmelli R, Nori SL et al. Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury. Cell. Death. Dis. 7(7), e2317 (2016).
  MedlineGoogle Scholar
• 38. Yaniz-Galende E, Chen J, Chemaly E et al. Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. Circ. Res. 111(11), 1434–1445 (2012).
  Medline CASGoogle Scholar
• 39. Ronnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell. Mol. Life Sci. 61(19–20), 2535–2548 (2004).
  Medline CASGoogle Scholar
• 40. Staser K, Yang FC, Clapp DW. Mast cells and the neurofibroma microenvironment. Blood 116(2), 157–164 (2010).
  Medline CASGoogle Scholar
• 41. Soonpaa MH, Rubart M, Field LJ. Challenges measuring cardiomyocyte renewal. Biochim. Biophys. Acta 1833(4), 799–803 (2013).
  Medline CASGoogle Scholar
• 42. Lázár E, Sadek HA, Bergmann O. Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur. Heart J. 38(30), 2333–2342 (2017).
  MedlineGoogle Scholar
• 43. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 83(1), 15–26 (1998).
  Medline CASGoogle Scholar
• 44. Laflamme MA, Murry CE. Heart regeneration. Nature 473(7347), 326–335 (2011).
  Medline CASGoogle Scholar
• 45. Laflamme MA, Murry CE. Regenerating the heart. Nat. Biotech. 23(7), 845–856 (2005).
  Medline CASGoogle Scholar
• 46. Etzion S, Battler A, Barbash IM et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J. Mol. Cell. Cardiol. 33(7), 1321–1330 (2001).
  Medline CASGoogle Scholar
• 47. Zimmet H, Krum H. Using adult stem cells to treat heart failure – fact or fiction? Heart. Lung. Circ. 17, S48–S54 (2008).
  MedlineGoogle Scholar
• 48. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3), 221–228 (1999).
  Medline CASGoogle Scholar
• 49. Liu N, Qi X, Han Z et al. Bone marrow is a reservoir for cardiac resident stem cells. Sci. Rep. 6(28739), 1–10 (2016).
  MedlineGoogle Scholar
• 50. Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem. Cell. Res. Ther. 7(1), 82–107 (2016).
  MedlineGoogle Scholar
• 51. Leong YY, Ng WH, Ellison-Hughes GM et al. Cardiac stem cells for myocardial regeneration: they are not alone. Front. Cardiovasc. Med. 4(47), 1–13 (2017).
  MedlineGoogle Scholar
• 52. Guerra S, Leri A, Wang X et al. Myocyte death in the failing human heart is gender dependent. Circ. Res. 85(9), 856–866 (1999).
  Medline CASGoogle Scholar
• 53. Anversa P, Kajstura J, Leri A et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113(11), 1451–1463 (2006).
  MedlineGoogle Scholar
• 54. Davis DR, Zhang Y, Smith RR et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS ONE 4(9), e7195 (2009).
  MedlineGoogle Scholar
• 55. Li C, Matsushita S, Li Z et al. c-kit positive cardiac outgrowth cells demonstrate better ability for cardiac recovery against ischemic myopathy. J. Stem. Cell. Res. Ther. 7(10), 1–17 (2017).
  Google Scholar
• 56. Valente M, Nascimento DS, Cumano A et al. Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis. Stem Cells Dev. 23(19), 2263–2273 (2014).
  Medline CASGoogle Scholar
• 57. Hensley MT, De Andrade J, Keene B et al. Cardiac regenerative potential of cardiosphere-derived cells from adult dog hearts. J. Cell. Mol. Med. 19(8), 1805–1813 (2015).
  MedlineGoogle Scholar
• 58. He JQ, Vu DM, Hunt G et al. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS ONE 6(11), e27719 (2011).
  Medline CASGoogle Scholar
• 59. Linke A, Müller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl Acad. Sci. USA 102(25), 8966–8971 (2005).
  Medline CASGoogle Scholar
• 60. Ellison GM, Vicinanza C, Smith AJ et al. Adult c-kit pos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154(4), 827–842 (2013).
  Medline CASGoogle Scholar
• 61. Tang XL, Rokosh G, Sanganalmath SK et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121(2), 293–305 (2010).
  MedlineGoogle Scholar
• 62. Fazel S, Cimini M, Chen L, Li S, Angoulvant D et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116(7), 1865–1877 (2006).
  Medline CASGoogle Scholar
• 63. Makkar RR, Smith RR, Cheng K et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised Phase I trial. Lancet 379(9819), 895–904 (2012). •• Provides signaling pathways involved in cardiomyocyte differentiation and regeneration.
  MedlineGoogle Scholar
• 64. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20(24), 3347–3365 (2006).
  Medline CASGoogle Scholar
• 65. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24(50), 7455–7464 (2005).
  Medline CASGoogle Scholar
• 66. Gao T, Furnari F, Newton AC. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell. 18(1), 13–24 (2005).
  Medline CASGoogle Scholar
• 67. Klinz F, Bloch W, Addicks K et al. Inhibition of phosphatidylinositol-3-kinase blocks development of functional embryonic cardiomyocytes. Exp. Cell Res. 247(1), 79–83 (1999).
  Medline CASGoogle Scholar
• 68. Naito AT, Tominaga A, Oyamada M et al. Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by phosphatidylinositol 3-kinase inhibitor LY294002. Exp. Cell Res. 291(1), 56–69 (2003).
  Medline CASGoogle Scholar
• 69. Faramoushi M, Amir Sasan R, Sari Sarraf V et al. Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude. J. Cardiovasc. Thorac. Res. 8(1), 26–33 (2016).
  MedlineGoogle Scholar
• 70. Naito AT, Akazawa H, Takano H et al. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ. Res. 97(2), 144–151 (2005).
  Medline CASGoogle Scholar
• 71. Ghosh-Choudhury N, Abboud SL, Nishimura R et al. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J. Biol. Chem. 277(36), 33361–33368 (2002).
  Medline CASGoogle Scholar
• 72. Vajravelu BN, Hong KU, Al-Maqtari T et al. C-Kit promotes growth and migration of human cardiac progenitor cells via the PI3K-AKT and MEK-ERK pathways. PLoS ONE 10(10), e0140798 (2015).
  MedlineGoogle Scholar
• 73. Shi B, Deng W, Long X et al. miR-21 increases c-kit(+) cardiac stem cell proliferation in vitro through PTEN/PI3K/Akt signaling. PeerJ. 5, e2859 (2017).
  MedlineGoogle Scholar
• 74. Shi B, Wang Y, Zhao R et al. Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit+ cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis. PLoS ONE 13(2), e0191616 (2018).
  MedlineGoogle Scholar
• 75. Kuang D, Zhao X, Xiao G et al. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res. Cardiol. 103(3), 265–273 (2008).
  Medline CASGoogle Scholar
• 76. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90(4), 1507–1546 (2010).
  Medline CASGoogle Scholar
• 77. Qi M, Elion EA. MAP kinase pathways. J. Cell Sci. 118(Pt 16), 3569–3572 (2005).
  Medline CASGoogle Scholar
• 78. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 40(12), 2707–2719 (2008).
  Medline CASGoogle Scholar
• 79. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81(2), 807–869 (2001).
  Medline CASGoogle Scholar
• 80. Avruch J. MAP kinase pathways: the first twenty years. Biochim. Biophys. Acta 1773(8), 1150–1160 (2007).
  Medline CASGoogle Scholar
• 81. Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24(1), 21–44 (2006).
  Medline CASGoogle Scholar
• 82. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90(4), 1507–1546 (2010).
  Medline CASGoogle Scholar
• 83. Bueno OF, De Windt LJ, Tymitz KM et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19(23), 6341–6350 (2000).
  Medline CASGoogle Scholar
• 84. Ruppert C, Deiss K, Herrmann S et al. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy. Proc. Natl Acad. Sci. USA. 110(18), 7440–7445 (2013).
  Medline CASGoogle Scholar
• 85. Dell'Era P, Ronca R, Coco L et al. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ. Res. 93(5), 414–420 (2003).
  MedlineGoogle Scholar
• 86. Schönwasser DC, Marais RM, Marshall CJ et al. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18(2), 790–798 (1998).
  Medline CASGoogle Scholar
• 87. Patel AL, Shvartsman SY. Outstanding questions in developmental ERK signaling. Development 145(14), dev143818 (2018).
  MedlineGoogle Scholar
• 88. Hubert F, Payan SM, Rochais F. FGF10 signaling in heart development, homeostasis, disease and repair. Front. Genet. 9(599), 1–7 (2018).
  MedlineGoogle Scholar
• 89. Fathi E, Nassiri SM, Atyabi N et al. Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol–dextran blend hydrogel in an ovine model of acute myocardial infarction. J. Tissue. Eng. Regen. Med. 7(9), 697–707 (2013).
  Medline CASGoogle Scholar